Fig. 4From: Real-world outcomes of PD-L1 inhibitors combined with thoracic radiotherapy in the first-line treatment of extensive stage small cell lung cancerKaplan–Meier OS for patients with risk factors. OS, overall survival; mo, monthsBack to article page